{ }
KR Choksey maintains a BUY rating on Rossari Biotech with a target price of Rs 1,034, reflecting a 31.4% upside from the current market price of Rs 787. Despite lower-than-expected Q2FY25 results due to challenges in the HPPC and TSC segments, the company showed year-on-year growth in revenue, gross profit, EBITDA, and PAT, driven by strong export performance. Adjustments to FY25E/FY26E EPS estimates have been made, but long-term growth potential remains positive with expected capacity additions in the specialty chemicals sector.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.